Redefining hemorrhoid therapy with endoscopic polidocanol foam sclerobanding.
| Autor: | Rao AG; Department of Clinical Medicine, Dow Medical College, Karachi 74200, Pakistan., Nashwan AJ; Department of Nursing & Midwifery Research, Hamad Medical Corporation, Doha 3050, Qatar. anashwan@hamad.qa. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | World journal of gastroenterology [World J Gastroenterol] 2024 Sep 28; Vol. 30 (36), pp. 4021-4024. |
| DOI: | 10.3748/wjg.v30.i36.4021 |
| Abstrakt: | Hemorrhoids are a common and painful condition, with conventional treatments such as endoscopic rubber band ligation (ERBL) and injection sclerotherapy often falling short due to high recurrence rates and significant post-operative pain. A clinical trial by Qu et al introduces a novel approach called endoscopic poli-docanol foam sclerobanding (EFSB). This multicenter randomized trial involved 195 patients with grade II and III internal hemorrhoids and demonstrated that EFSB significantly reduced recurrence rates and post-procedural pain while improving symptom relief and patient satisfaction compared to ERBL. The study's strengths include its robust design, comprehensive outcome evaluation, and patient-centered approach. Despite limitations such as the single-blind design and relatively short follow-up period, the findings suggest that EFSB could enhance clinical practice by offering a more effective and patient-friendly treatment option. Further research is needed to validate these results and explore the long-term benefits and cost-effectiveness of EFSB. Competing Interests: Conflict-of-interest statement: All the authors declare that they have no conflict of interest. (©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|